Crossref
The European Innovation Council supports innovative portfolios in health biotech
Nature Biotechnology · 2024
DOI: 10.1038/s41587-024-02416-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Biotechnology, 2024. Verfasst von Iordanis Arzimanoglou. Beteiligte Einrichtung: Former Program Manager for Health and Biotechnology, EIC, Brussels, Belgium. d.arzimanoglou@gmail.com. Hauptthemen laut MEDLINE: Biotechnology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
BiotechnologyHumansEuropeEuropean UnionInvestments
Autor:innen und Institutionen
- Former Program Manager for Health and Biotechnology, EIC, Brussels, Belgium. d.arzimanoglou@gmail.com.
- Senior Advisor, Health Biotech, Brussels, Belgium. d.arzimanoglou@gmail.com.
Zitieren
APA
Arzimanoglou, I. (2024). The European Innovation Council supports innovative portfolios in health biotech. Nature Biotechnology. https://doi.org/10.1038/s41587-024-02416-8
Vancouver
Arzimanoglou I. The European Innovation Council supports innovative portfolios in health biotech. Nature Biotechnology. 2024. doi:10.1038/s41587-024-02416-8
BibTeX
@article{Arzimanoglou2024,
author = {Arzimanoglou, Iordanis},
title = {The European Innovation Council supports innovative portfolios in health biotech},
journal = {Nature Biotechnology},
year = {2024},
doi = {10.1038/s41587-024-02416-8}
}
EUVIMED